OR WAIT 15 SECS
© 2021 MJH Life Sciences™ and Ophthalmology Times. All rights reserved.
Toronto-QLT Inc. is temporarily lowering the price of verteporfin (Visudyne, Novartis and QLT Inc.) by $55 after the Centers for Medicare & Medicaid Services (CMS) lowered the amount for which it would reimburse physicians.